Skip to main content

Table 1 Blood test findings

From: Fulminant myocarditis during postoperative adjuvant chemotherapy for lung cancer with atezolizumab: a case report

(A)

Normal range

(B)

Normal range

White blood cell (/μl)

4300 (3300–8600)

White blood cell (/μl)

6900 (3300–8600)

Lymph (%)

18.5 (25.0–45.0)

Lymph (%)

23 (25.0–45.0)

Hemoglobin (g/dl)

12.0 (11.6–14.8)

CK (U/L)

130 (41–153)

ALT (U/L)

27 (7–23)

CK-MB (ng/ml)

3 (0–10)

AST (U/L)

23 (13–30)

Troponin I (pg/ml)

538.8 (0.0–26.2)

LDH (U/L)

285 (124–222)

BNP (pg/ml)

503.0 (0.0–18.4)

CRP (mg/dl)

4.76 (0.00–0.14)

Myoglobin (ng/ml)

200 (0–116)

BUN (mg/dl)

0.89 (8.0–22.0)

  

Cre (mg/dl)

0.83 (0.46–0.79)

  

Na (mmol/dl)

136 (138–145)

  

K (mmol/dl)

4.5 (3.6–4.8)

  

Cl (mmol/dl)

99 (101–108)

  

Ca (mg/dl)

9.0 (8.8–10.1)

  

FT4 (ng/dl)

0.89 (0.70–1.48)

  

FT3 (pg/ml)

2.16 (1.68–3.67)

  

TSH (μIU/mL)

2.05 (0.61–4.23)

  
  1. ALT alanine aminotransferase, AST aspartate aminotransferase, LDH lactate dehydrogenase, CRP Creactive protein, BUN blood urea nitrogen, Cre creatinine, FT4 free thyroxine, FT3 free triiodothyronine, TSH thyroid stimulating hormone, CK creatine phosphokinase, CK-MB creatine kinase MB, BNP brain natriuretic peptide